TickerKhojOpen the scanner

Comparison · NSE · data 2026-11-02

Alembic Pharmaceuticals Limited vs PFIZER LIMITED

In plain words

Size: PFIZER LIMITED is about 1.1 times the market value of Alembic Pharmaceuticals Limited.

Return on equity: PFIZER LIMITED 17.2% vs Alembic Pharmaceuticals Limited 12.3%.

Profit growth over 3 years: Alembic Pharmaceuticals Limited 25.4% a year vs PFIZER LIMITED 5% a year.

Debt to equity: Alembic Pharmaceuticals Limited 0.25 vs PFIZER LIMITED 0.02.

Differences in the numbers, not a recommendation of either stock.

Side by side

APLLTDPFIZER
Price₹804.6₹3,630.6
Market cap₹15,682 cr₹16,867 cr
P/E22.822.6
P/B——
ROE12.3%17.2%
ROCE11.8%20.0%
Debt / equity0.250.02
Operating margin10.6%34.4%
Dividend yield1.50%2.03%
Sales growth, 3 years (yearly)9.0%1.3%
Profit growth, 3 years (yearly)25.4%5.0%
1-year return-10.6%-31.8%
Revenue, last 12 months₹7,784 cr₹2,570 cr
Net profit, last 12 months₹693 cr₹735 cr
Latest quarterJun 2026Jun 2026
Quarter net profit₹173 cr₹204 cr
Quarter profit vs a year earlier+12.1%+6.6%
Promoter holding69.87%63.92%
Health checkStrong (6.9/10)Average (6/10)

Common questions

Which has a higher P/E, Alembic Pharmaceuticals Limited or PFIZER LIMITED?

Alembic Pharmaceuticals Limited trades at the higher P/E (22.8 against 22.6). A higher P/E means the market pays more for each rupee of past earnings; on its own it does not say which is better.

Which earns a higher return on equity?

PFIZER LIMITED (17.2% against 12.3%).

Which carries more debt?

Alembic Pharmaceuticals Limited has the higher debt-to-equity ratio (0.25 against 0.02).

APLLTD pagePFIZER page

Share on WhatsAppShare on Telegram